DR. DMITRY KARAYEV M.D. NPI 1174783260

NPI Details

DR. Dmitry Karayev, M.D. is an internal medicine in Los Angeles, CA with 19 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Dmitry Karayev, M.D. NPI is 1174783260. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TUFTS UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2006

The provider's business location address is:

8640 W 3RD ST
SUITE 300
LOS ANGELES, CA
ZIP 90048-384
Phone: (310) 659-7878
Fax: (310) 659-7117

The NPI 1174783260 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, immune globulin (bivigam), 500 mg (HCPCS:J1556)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Vitamin d-3 level (HCPCS:82306)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Hemoglobin a1c level, by device for home use (HCPCS:83037)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Measurement of complement function (immune system proteins) (HCPCS:86161)
• Uric acid level, blood (HCPCS:84550)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Tuberculosis test, enumeration of t-cells (HCPCS:86481)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Rheumatoid factor level (HCPCS:86431)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Screening test for autoimmune disorder (HCPCS:86038)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Antibody identification test for white blood cell antibodies (HCPCS:86021)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection into tendon or ligament (HCPCS:20550)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 6/11/2008 and was last updated on 2/14/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: